NCT05446116

Transfemoral Versus Transradial Partial Splenic Artery Embolization in Patients With Hypersplenism

Transfemoral Versus Transradial Partial Splenic Artery Embolization in Patients With Hypersplenism, a Randomized Controlled Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 112 (actual)
• Sponsor: Zagazig University · Other Government
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The present study aimes at comparing the transradial and transfemoral approaches for partial splenic embolization in patients with hypersplenism.

Detailed description

Since its development in 1979, partial splenic embolization (PSE) has been universally accepted to treat patients with hypersplenism in preference to surgical splenectomy. The spleen is the primary source of antibodies, lymphocyte production, and responsible for phagocytosis of white cells. Additionally, it plays an essential role in the immune system. Unlike splenectomy, partial splenic embolization (PSE) maintained partial splenic function and was thought to be an effective alternative to treat thrombocytopenia and leukopenia resulted from hypersplenism with fewer complications. PSE is usually performed using a femoral artery approach that requires bed rest for a few hours. Recently, the transradial approach, with less obvious need for bed rest, has been more widely applied for cardiovascular intervention.

Conditions

• Hypersplenism

Interventions

Type	Name	Description
PROCEDURE	partial splenic artery embolization	embolization of the splenic artery for the treatment of hypersplenism

Timeline

• Start date: 2019-06-01
• Primary completion: 2021-10-01
• Completion: 2021-10-18
• First posted: 2022-07-06
• Last updated: 2022-07-06

Locations

1 site across 1 country: Egypt